局部化高风险前列腺癌的宿主是受受体较低的亚群,易受HER2抑制
Scott Wilkinson1, Anson T Ku1, Rosina T Lis1
1Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA.
medRxiv : the preprint server for health sciences
|February 19, 2024
概括
高风险前列腺癌患者经常出现复发. 这项研究揭示了HER2活性与雄激素受体 (AR) 活性相对抗,确定了一组AR低,HER2高细胞的子集,这些细胞可以被HER2抑制剂准.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 局部高风险前列腺癌由于高复发率而带来挑战.
- 新辅助性激素疗法旨在治疗微转移性疾病,但需要更好的基线分析来评估治疗反应.
结论:
- 前列腺瘤在抗雄激素治疗之前表现出AR活性较低的表型,这可以被利用.
- 低AR活性,高HER2活性细胞已经存在并对ADT有抗性.
- 单独或与酶胺一起向HER2,为这些耐药细胞提供了一种治疗策略.
更多相关视频
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.8K
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.1K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
